IMIC

IMIC is a U.S.-based clinical research center and dedicated trial site focused on conducting industry-sponsored studies for new drugs, devices, and diagnostics. The organization operates as a multi-specialty research site serving diverse patient populations in South Florida, with activity spanning CNS, respiratory, metabolic, hepatology, gastroenterology, and vaccine studies. IMIC appears to function primarily as a healthcare services and clinical trial execution company rather than a therapeutics developer, supporting patient recruitment, study conduct, and data collection. In September 2024, IMIC became part of the Rovia Clinical Research site network, which positions it within a broader platform serving pharma, biotech, and CRO sponsors.